US Earnings Financial Results SEC Filings — April 10, 2026

10-04-2026

For the three months ended February 28, 2026, Simulations Plus reported total revenues of $24,291 thousand, up 8.3% YoY from $22,432 thousand, with software revenues increasing 8.5% to $14,635 thousand and services up 7.9% to $9,656 thousand, driving net income to $4,535 thousand (+47.5% YoY). For the six months ended February 28, 2026, total revenues rose 3.3% YoY to $42,712 thousand; however, software revenues declined 2.8% to $23,518 thousand while services grew 11.9% to $19,194 thousand. Profitability strengthened markedly with six-month operating income up 123.6% YoY to $6,343 thousand, though cash and cash equivalents decreased to $25,727 thousand from $30,853 thousand at August 31, 2025.

• ·Net cash provided by operating activities six months: $10,646 thousand vs $4,395 thousand prior year (+142%).
• ·Net cash used in investing activities six months: $16,248 thousand vs $2,454 thousand prior year.
• ·Accounts receivable increased to $18,170 thousand from $9,717 thousand at Aug 31, 2025.
• ·Deferred revenue increased to $5,530 thousand from $2,696 thousand at Aug 31, 2025.
• ·Stock-based compensation six months: $3,238 thousand.

10-04-2026

EvoAir Holdings Inc. (EVOH) reported revenue of $67,588 for the three months ended February 28, 2026, down 5% YoY from $71,124, while gross profit improved sharply to $5,444 from $1,058; however, for the six months ended, revenue declined 28% YoY to $88,039 from $123,053 amid ongoing losses. Net loss attributable to equity holders narrowed to $939,020 in Q2 FY2026 (three months) from $1,205,822 YoY and to $1,917,162 for six months from $5,761,223, driven by a 65% reduction in operating expenses to $2,046,509. Cash used in operations improved slightly to $716,152 for six months, with net cash increase of $75,338, though ending cash fell to $45,835 from $199,461 YoY.

• ·Shareholding in subsidiary WKL Guanzhe Green Technology Guangzhou Co Ltd increased from 62.5% to 66.67% on February 6, 2026.
• ·Net cash generated from financing activities for six months: $853,410 in 2026 vs $744,728 in 2025.
• ·Cash and cash equivalents at end of six months: $45,835 in 2026 (down from $199,461 in 2025).
• ·EPS basic and diluted (six months): ($0.07) in 2026 vs ($0.22) in 2025.

10-04-2026

The Children's Place, Inc. reported FY2026 net sales of $1,208,830 thousand, down 12.8% from $1,386,269 thousand in FY2025, with gross profit declining 21.3% to $361,558 thousand (29.9% of sales) from $459,461 thousand (33.1%). Operating loss widened to $57,212 thousand (-4.7% of sales) from $13,701 thousand (-1.0%), and net loss increased 52.7% to $88,263 thousand from $57,819 thousand. While asset impairment charges fell sharply 92.8% to $2,004 thousand from $28,000 thousand, both U.S. segment sales ($1,103,459 thousand, down to -3.8% margin) and International ($105,371 thousand, to -14.9% margin) deteriorated.

• ·Q4 FY2026 operating loss of $40,870 thousand, largest quarterly loss.
• ·Equity compensation plans have 329,810 securities remaining available.
• ·FY2026 diluted loss per common share $4.01 GAAP vs $3.70 adjusted.
• ·Third quarter net sales flat at 28.1% of full year vs prior year.

10-04-2026

ASP Isotopes Inc. reported FY2025 revenue of $23,849 up 475% YoY from $4,144, driven by the new Construction services segment at $18,175 while Specialist isotopes grew 44% to $5,674; Nuclear fuels revenue declined to $0 from $200. However, net loss attributable to shareholders widened to $175,092 from $35,114 due to higher operating expenses ($63,313 vs $27,953), R&D ($12,358 vs $3,139), SG&A ($48,238 vs $24,814), and a $123,719 change in fair value of convertible notes payable. Total assets expanded to $498,020 from $94,348, with cash and equivalents rising to $285,563 from $61,890 supported by $371,600 in financing activities, though operating cash use increased to $37,780 from $16,696.

• ·Cash increased by $223,026 net from operations, investing, and financing activities.
• ·Weighted average shares outstanding increased to 83,013,594 from 55,671,805.
• ·Headline loss per share $0.83 vs $0.45 FY2024.
• ·Segment assets: Specialist isotopes $323,690 (up from $71,771), Nuclear fuels $94,252 (up from $22,577), Construction services $80,078 (new).

10-04-2026

FGI Industries Ltd. reported revenue of $130,528,652 for the year ended December 31, 2025, a slight 1.0% decline from $131,818,073 in 2024, with gross profit also down 0.5% to $35,251,092. Operating loss widened 14.4% to $2,402,056 amid higher G&A expenses (+8.9%), while net loss attributable to shareholders deteriorated sharply by 411.2% to $6,139,526, driven by increased other expenses and tax provisions. Cash and equivalents fell to $1,899,801 from $4,558,160, and total shareholders' equity decreased to $15,610,041 from $21,565,650.

• ·Adjusted net loss attributable to shareholders was $2,555,789 in 2025 vs. $939,648 in 2024, worsening 172.0%.
• ·Accounts receivable decreased to $13,847,762 from $20,293,555; inventories increased to $15,292,742 from $13,957,867.
• ·Short-term loans reduced to $11,868,828 from $14,502,367; accounts payable rose to $24,687,900 from $19,349,529.
• ·Basic and diluted loss per share was $3.20 in 2025 vs. $0.63 in 2024.

10-04-2026

SOBR Safe, Inc.'s 10-K filing details extensive business risks, including heavy reliance on its SOBRsafeTM technology for personal alcohol awareness tracking devices, limited operating history, manufacturing challenges with third-party suppliers, and potential product defects or market non-acceptance that could impair revenue growth. Additional risks encompass cyber vulnerabilities, regulatory compliance costs, talent retention issues, supply chain disruptions, and stock volatility with threats of Nasdaq delisting. Marketing efforts focus on e-commerce, SEO/SEM, partnerships, and brand development, but face hurdles from technological obsolescence and competition.

• ·Risk of inability to meet future capital needs or sustain profitability, potentially leading to reduced operations.
• ·Dependency on third-party manufacturers for key components, with risks of delays, quality issues, or sole supplier disruptions.
• ·Potential for common stock delisting from Nasdaq and classification as penny stock, reducing liquidity.

10-04-2026

Quince Therapeutics reported a net loss of $83.979 million for the year ended December 31, 2025, widening 48% from $56.828 million in 2024, primarily due to a 90% increase in R&D expenses to $35.382 million and significant fair value adjustments for warrants ($21.470 million) and debt. While general and administrative expenses declined 14% to $15.047 million and goodwill impairment was eliminated (vs. $17.130 million prior year), total operating expenses rose slightly 1% to $58.068 million, cash used in operations increased 30% to $41.425 million, and cash equivalents fell to $5.809 million from $6.212 million.

• ·Stockholders’ equity turned to deficit of $35.714 million at Dec 31, 2025 from positive $30.146 million at Dec 31, 2024.
• ·Warrant liabilities recorded at $32.150 million as of Dec 31, 2025.
• ·Intangible assets increased to $67.819 million from $60.045 million.
• ·Weighted average shares outstanding increased to 50,096,897 in 2025 from 43,262,269 in 2024.
• ·Filing date: April 10, 2026.

10-04-2026

Brownie's Marine Group, Inc. reported total net revenues of $7,516,687 for the year ended December 31, 2025, down 7.99% YoY from $8,169,668, driven by declines in Legacy SSA Products (-1.87%), Ultra-Portable Tankless Dive Systems (-9.33%), Redundant Air Tank Systems (-12.00%), and Guided Tour Retail (-100%), despite growth in High Pressure Gas Systems (+14.83%). Liquidity strengthened with working capital surging 240.3% to $579,074 from $170,175, and current liabilities decreasing 14.0%. However, cash used in operating activities was $170,644 (improved from $293,434 prior year), and the company disclosed inadequate internal controls over revenue recognition.

• ·Shareholder-approved equity plans: 1,800,000 outstanding options/warrants/rights at weighted average exercise price $0.0447; 23,200,000 securities available for future issuance.
• ·Non-shareholder-approved equity plans: 28,869,400 outstanding options/warrants/rights at weighted average exercise price $0.0448; none available for future issuance.
• ·Net cash used in investing activities improved to $(14,178) from $22.
• ·Net cash used in financing activities: $(75,028) vs. provided $280,022 prior year.
• ·Inadequate internal controls over revenue recognition disclosed.

10-04-2026

GD Culture Group Ltd reported a massive net loss of $164,065,993 for the three months ended March 31, 2026, compared to $977,510 in the prior year period, driven primarily by a $162,483,197 unrealized loss on digital assets; operating expenses also rose to $1,649,804 from $937,877 YoY. Total assets declined 24.4% QoQ to $506,708,159 from $670,158,753, mainly due to the drop in digital assets from $662,996,878 to $500,613,681, while shareholders' equity fell to $504,077,910 from $668,142,145. Cash and cash equivalents plummeted 96.3% QoQ to $16,805, though net cash used in operations improved slightly to $649,250 from $831,308 YoY.

• ·Loss per share basic and diluted: $(2.53) for Q1 2026 vs $(0.08) for Q1 2025.
• ·Shares issued increased by 3,441,600 via exercise of May 2025 prefunded warrants, generating $1,744.
• ·Net cash provided by financing activities: $310,000 from related party loans in Q1 2026.
• ·Intangible assets, net: $4,790,808 as of March 31, 2026 (down from $5,090,238).
• ·Filing date: April 10, 2026.

10-04-2026

ChampionsGate Acquisition Corp, a blank check company, reported net income of $1,175,395 for the year ended December 31, 2025, driven by $1,778,580 in interest income from its $76,902,330 Trust Account following its IPO, compared to a $250,846 net loss through December 31, 2024. However, the company recorded an operating loss of $603,185, up from $250,846 prior, with no revenues and increasing formation costs to $447,281 from $218,941; shareholders' deficit also worsened to $(1,572,569) from $(193,941). Total assets grew significantly to $76,992,999 post-IPO proceeds of $74,750,000, while current liabilities decreased to $168,238 from $489,046.

• ·Over-allotment option exercised in full on May 29, 2025, resulting in 283,064 additional Class B ordinary shares.
• ·IPO included 7,475,000 public units sold.
• ·Promissory note - related party of $331,927 as of Dec 31, 2024 was forgiven or converted, contributing $108,602 to additional paid-in capital.
• ·Working capital loan - related party of $151,671 outstanding as of Dec 31, 2025.

10-04-2026

TV Channels Network Inc. reported no revenues for both 2025 and 2024, with net losses narrowing slightly to $(131,954) from $(138,812), driven by a 5% reduction in general and administrative expenses to $131,954. However, cash and cash equivalents declined to $191 from $266, total assets fell 28% to $143,607, and total liabilities rose 18% to $488,452, deepening the stockholders' deficit to $(344,845). Operating cash use improved marginally to $75 from $108.

• ·Rent expenses decreased to $66,854 from $68,128; legal and professional expenses fell to $48,080 from $55,300.
• ·Operating lease right-of-use asset declined to $137,866 from $194,567; total lease liabilities reduced to $152,245 from $208,692.
• ·Net loss per common share improved to $(0.0031) from $(0.004).
• ·Weighted average remaining lease term shortened to 2.25 years from 3.25 years.

10-04-2026

America Great Health's FY2025 annual 10-K shows revenue growth of 33% YoY to $391,743, gross profit more than doubling to $339,121 amid lower COGS and SG&A expenses, and net loss narrowing 41% to $(721,242) from $(1,226,362). However, total assets declined 7% to $301,817, cash fell 20% to $44,056, total liabilities rose 11% to $6,045,644, and shareholders' deficit worsened to $(5,743,827). Operating cash use improved to $(332,862) but remains negative, supported by financing inflows.

• ·Accounts receivable dropped to $0 as of June 30, 2025 from $55,100.
• ·Due to related party increased to $1,251,639 as of June 30, 2025 from $1,110,196.
• ·Long term loan rose to $2,224,697 as of June 30, 2025 from $1,833,577.
• ·Property and equipment, net declined to $28,115 as of June 30, 2025 from $42,903.
• ·Net cash provided by financing activities was $321,532 in FY2025, down from $617,403.

10-04-2026

Scilex Holding Co's 2025 net revenue declined 47% YoY to $30,253 from $56,590, with ZTlido dropping 51% to $25,626, ELYXYB down 9% to $3,798, and GLOPERBA falling 37% to $151, while Vivasor added $678. Net loss widened dramatically to $374,053 from $72,807, driven by SG&A expenses surging 124% to $266,884, R&D up 115% to $20,710, and a $73,358 goodwill impairment. Positively, SP-102 Phase 3 trial met primary endpoint with LSM difference of -0.55 (p=0.003) and key secondary ODI -3.38 (p=0.015).

• ·Total current liabilities $483,652 at Dec 31, 2025 (up from $259,635)
• ·Cash and cash equivalents $4,955 at Dec 31, 2025 (up from $3,272)
• ·Accounts receivable $15,244 at Dec 31, 2025 (down from $26,442)
• ·Accrued rebates and fees $231,756 at Dec 31, 2025 (up from $162,517)
• ·Equity method investment at fair value $127,040 + $32,363 (pledged) at Dec 31, 2025
• ·Digital assets $64,711 at Dec 31, 2025

10-04-2026

Cumulus Media Inc reported net revenue of $741,695 thousand for the year ended December 31, 2025, down 10.3% from $827,076 thousand in 2024, while Adjusted EBITDA declined 37.1% to $52,006 thousand. Operating loss narrowed 42.4% to $(138,137) thousand and net loss improved 29.1% to $(200,702) thousand, driven by cost reductions including content costs down 16.3% and corporate expenses down 16.4%; however, SG&A expenses were up slightly 0.3%. Cash flow from operations worsened to net use of $21,336 thousand from $3,119 thousand.

• ·Term Loan due 2026 balance: $99 thousand (down from $10,449 thousand)
• ·2020 Revolving Credit Facility draw: $1,985 thousand (from $0)
• ·Impairment of intangible assets: $109,829 thousand (down 51.1% from $224,481 thousand)
• ·Restructuring costs: $11,089 thousand
• ·Non-routine legal expenses: $13,153 thousand
• ·Net cash used in investing activities: $7,859 thousand (worsened from $4,231 thousand)
• ·Net cash provided by financing activities: $47,338 thousand (vs used $9,474 thousand)

10-04-2026

CXJ Group reported revenue growth of 125% YoY to $145,267 for the three months ended February 28, 2026, and 7.8% YoY to $301,674 for the nine months, with cash and cash equivalents surging to $144,747 from $10,037 year-to-date. However, gross profit declined 18.8% YoY to $180,607 over nine months, operating losses widened to $(99,216) for the quarter and $(244,115) for nine months, and stockholders' equity deteriorated to $(1,845,564) from $(1,555,111). Total assets grew to $448,234 from $300,175, driven by higher current liabilities including advances received at $1,097,429.

• ·Net cash provided by operating activities for nine months ended Feb 28, 2026: $129,802 (vs used $395,784 prior year)
• ·Selling and distribution expenses increased to $94,459 for three months (65% YoY) and $192,482 for nine months (27% YoY)
• ·Accumulated other comprehensive income declined to $(14,598) from $31,567
• ·Weighted average shares outstanding: 102,270,517 (basic and diluted)

10-04-2026

Patriot Gold Corp reported a reduced net loss of $1,879,452 for FY 2025 compared to $3,149,619 in FY 2024, driven by lower operating expenses ($1,897,861 vs $2,480,564) and no revenues versus $361,523 prior year. However, total assets declined sharply to $179,103 from $531,035, cash dropped to $57,294 from $401,207, current liabilities rose to $2,027,613 from $738,305, and stockholders' equity worsened to $(1,848,510) from $(207,270). Cash used in operations improved slightly to $1,002,318 from $1,207,886, supported by $664,095 from a related-party note.

• ·Stock options outstanding decreased to 6,720,000 at $0.10 exercise price (3.11 years remaining contractual life, $0 aggregate intrinsic value).
• ·Equity compensation plans: 2012 Plan (3,525,000 options), 2014 Plan (4,815,000 options), 2019 Plan (9,500,000 available).
• ·Convertible note payable to related party: $664,095 as of Dec 31 2025.
• ·Accounts payable to related parties: $490,000 (2025) vs $280,000 (2024).

10-04-2026

NRUC reported Q3 FY2026 net income of $22.7 million, a sharp 74% YoY decline from $86.1 million primarily due to $32.4 million in derivative losses, while YTD net income fell 30% YoY to $47.0 million. However, adjusted net income rose slightly 2% YoY to $67.7 million in Q3 with stable Adjusted TIER at 1.19, supported by 12% YoY growth in net interest income to $79.6 million from higher loan volumes. Total assets expanded 5% YoY to $39.7 billion, driven by loan portfolio growth.

• ·Q3 FY2026 derivative gains (losses): -$32.4 million vs +$40.1 million in Q3 FY2025
• ·YTD FY2026 non-interest income loss of $62.4 million, worsened from $25.2 million loss YoY
• ·Loan portfolio: Long-term fixed-rate loans average balance up 3% YoY to $32.0 billion
• ·Short-term borrowings average balance up 15% YoY to $5.0 billion in Q3

10-04-2026

Balance Labs, Inc. reported de minimis revenue of $6,000 for the year ended December 31, 2025, up from $0 in 2024, but posted a sharply widened net loss of $31,768,325 versus $528,223, driven by surging operating expenses to $13,111,607 (including $12,893,767 in salaries) and $18,662,718 in net other expenses featuring a $16,595,746 loss on debt settlement. The balance sheet improved with total assets rising 316% to $397,506, cash surging to $358,975 from $13,199, liabilities declining 27% to $3,773,845, and stockholders' deficit narrowing to $(3,376,339) from $(5,071,106); however, this was accompanied by significant dilution as shares outstanding more than doubled to 46,852,319. Net cash used in operations increased to $257,024 from $157,110, offset by $602,800 in related-party financing.

• ·Property and Equipment, net: $0 as of Dec 31, 2025 and 2024.
• ·Unrealized loss on marketable securities: $43,845 in 2025 vs. $25,536 in 2024.
• ·Net cash used in operating activities: $257,024 in 2025 vs. $157,110 in 2024.
• ·Proceeds from short-term advances - related parties: $84,800 in 2025 vs. $57,500 in 2024.
• ·Shares issued for services/compensation: 8,510,531 shares.
• ·Shares issued for debt conversion: 16,667,788 shares.

10-04-2026

Apple iSports Group, Inc. reported zero net revenues for FY2025, with net loss expanding significantly to $6,407,709 from $2,821,336 in FY2024, driven by sharply higher operating expenses of $6,592,032 (up 93% YoY). However, total assets grew to $2,467,566 from $272,091, stockholders' deficit narrowed to $(4,061,454) from $(6,369,273), and cash & equivalents increased to $55,938 from $42,167, bolstered by financing inflows and loan conversions to equity. Cash burn from operations improved, using $1,664,244 versus $2,356,400 prior year.

• ·Common shares increased by 11,299,666 via loan conversions, subsidiary stock issuance, and other activities.
• ·Deferred financing costs rose to $2,295,042 total (current + non-current) from zero.
• ·Related party loans payable decreased to $2,261,484 from $3,597,442, partly due to $2,682,970 conversion to equity.
• ·No cash paid for interest or income taxes in either year.
• ·Foreign currency translation adjustment was a loss of $463,340 in 2025 vs gain of $414,337 in 2024.

10-04-2026

Graphene & Solar Technologies Ltd reported zero revenue for the three months ended December 31, 2025, consistent with the prior year period, while total operating expenses declined 21.3% YoY to $759,871, driven by lower professional fees (-24.5%) but offset by higher general and administrative expenses (+124.6%), resulting in a reduced net loss of $862,697 versus $1,042,617 YoY. Net cash used in operating activities increased slightly to $107,078 from $99,555, leading to a lower ending cash balance of $78,842 compared to $103,019. Other comprehensive income improved to $171,392 from $102,104.

• ·Professional fees decreased to $714,731 from $945,655 YoY.
• ·Interest expense increased to $59,092 from $19,597 YoY.
• ·Loss on extinguishment of debt $43,734 in 2025 (none in 2024).
• ·Net cash from financing activities $272,900 in 2025 vs $199,416 in 2024.
• ·Convertible notes net increased to $258,701 from $184,829 (Sep 30, 2025).
• ·Stockholders' equity deficiency improved slightly to $(4,422,745) from $(4,556,693) QoQ.

10-04-2026

Two Hands Corp reported zero sales and gross profit for the year ended December 31, 2025, a 100% decline from $709,526 and $51,808 in 2024, respectively. Operating expenses decreased 13% to $1,057,326, leading to a reduced net loss of $484,854 from $2,433,970 the prior year, aided by other income/expenses swinging to a $572,472 gain. However, net cash used in operating activities worsened to $807,887 from $250,503.

• ·All four quarters of 2025 had zero sales, with Q4 net income of $598,232 driven by $930,910 other income, while prior quarters reported losses.
• ·Loss on settlement of non-redeemable convertible notes and promissory notes: $1,177,540 in 2025 vs $(1,093,735) in 2024.
• ·Net cash used in investing activities: $60,000 in 2025 (none in 2024).

10-04-2026

For the three months ended February 28, 2026, Stimcell Energetics Inc. reported a reduced net loss of $90,566, down 35.6% YoY, driven by a 45.1% decrease in total operating expenses to $71,908, including a 75.0% drop in general and administrative expenses; however, research and development costs surged 7,316% to $36,561 and interest expenses rose 97.4%. Over nine months, the net loss widened 91.9% YoY to $665,916 amid a 92.1% increase in operating expenses to $617,308, fueled by 332.5% higher G&A and massive R&D growth, while cash dwindled to $10,257 and the working capital deficit expanded 34.7% to $1,678,420.

• ·Net cash used in operating activities for nine months ended February 28, 2026: $268,570, up from $83,152 YoY.
• ·Proceeds from notes due to related parties for nine months: $264,248.
• ·Shares issued for services: 375,000 in August 2025 ($120,000) and 375,000 in November 2025 ($130,000).
• ·Due to related parties increased to $605,231 as of February 28, 2026 from $448,536 at May 31, 2025.
• ·Notes and advances due to related parties: $779,992 as of February 28, 2026.